form8k07380004_01162015.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 16, 2015
 
PHARMACYCLICS, INC.
(Exact name of registrant as specified in its charter)
     
Delaware
000-26658
94-3148201
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
     
995 E. Arques Avenue, Sunnyvale, California
94085-4521
(Address of principal executive offices)
(Zip Code)

Registrant’s telephone number, including area code: (408) 774-0330
 
 
(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 

 
 
Item 5.02.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
 
On January 16, 2015, the Compensation Committee of Pharmacyclics, Inc. (the “Company”) approved the grant of Restricted Stock Units pursuant to the 2014 Equity Incentive Award Plan (the “RSUs”) to certain of the Company’s officers including in the following amounts: (i) 15,000 to Mahkam Zanganeh, the Company’s Chief Operating Officer and (ii) 22,000 to Manmeet Soni, the Company’s Chief Financial Officer and Treasurer.  All such RSUs vest 25% on each of February 28, 2016, February 28, 2017, February 28, 2018 and February 28, 2019.
 
 
 

 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.
 
January 23, 2015
 
PHARMACYCLICS, INC.
 
 
By:
/s/ Manmeet Soni
 
Name:  Manmeet Soni
 
Title:    Chief Financial Officer